trending Market Intelligence /marketintelligence/en/news-insights/trending/l6sFriOXoMm5puiUbBRfVA2 content esgSubNav
In This List

Onconova Therapeutics to raise $3.4M from share sale to accredited investors

Blog

A Pharmaceutical Company Capitalizes on M&A Activity with Brokerage Research

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021


Onconova Therapeutics to raise $3.4M from share sale to accredited investors

Cancer therapy-focused biotechnology company Onconova Therapeutics Inc. entered into a stock purchase agreement with certain institutional and accredited investors to raise gross proceeds of about $3.4 million.

The company will sell 2,136,193 common shares at $1.60 apiece under the agreement, and the offering is expected to close on or about Sept. 25.

H.C. Wainwright & Co. is the placement agent for the offering.